ArticleEndocrine connections2026

Elexacaftor-tezacaftor-ivacaftor enhances first-phase insulin secretion and improves glucose control in cystic fibrosis.

Anna Edlund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.